Vaccine Production

Vaccines are produced in large scale as they need to be administered to large populations of children and adults to be effective as a public health tool. This large scale production is often a challenge.

Stages of vaccine production

Vaccine production has several stages. Process of vaccine manufacture has the following steps:

  • Inactivation – This involves making of the antigen preparation
  • Purification – The isolated antigen is purified
  • Formulation – The purified antigen is combined with adjuvants, stabilizers and preservatives to form the final vaccine preparation.

Generating the antigen from the microbe

The initial production involves generation of the antigen from the microbe. For this the virus or microbe is grown either on primary cells such as chicken eggs (e.g. in influenza) or on cell lines or cultured human cells (e.g. Hepatitis A). Bacteria against which the vaccines are developed may be grown in bioreactors (e.g. Haemophilus influenzae type b). The antigen may also be a toxin or toxoid from the organism (e.g. Diphtheria or tetanus) or it may be part of the microorganism as well. Proteins or parts from the organism can be generated in yeast, bacteria, or cell cultures. Bacteria or viruses may be weakened using chemicals or heat to make the vaccine (e.g. polio vaccine).

Isolation of the antigens

After the antigen is generated, it is isolated from the cells used to generate it. For weakened or attenuated viruses no further purification may be required. Recombinant proteins need many operations involving ultrafiltration and column chromatography for purification before they are ready for administration.

Adjuvants, stabilizers and preservatives

Once the antigen is developed the vaccine is formulated by adding adjuvants, stabilizers, and preservatives. The role of the adjuvant is to enhance the immune response of the antigen. The stabilizers increase the storage life, and preservatives allow the use of multi dose vials.
It is difficult to develop and produce combination vaccines due to the possibility of incompatibilities and interactions among the antigens and other ingredients of the vaccines.

Vaccine Production Requirements

The product needs to be protected from air, water and human contamination. The environment needs to be protected from spillage of the antigens

Further Reading

Last Updated: Jun 5, 2019

Dr. Ananya Mandal

Written by

Dr. Ananya Mandal

Dr. Ananya Mandal is a doctor by profession, lecturer by vocation and a medical writer by passion. She specialized in Clinical Pharmacology after her bachelor's (MBBS). For her, health communication is not just writing complicated reviews for professionals but making medical knowledge understandable and available to the general public as well.


Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Mandal, Ananya. (2019, June 05). Vaccine Production. News-Medical. Retrieved on August 07, 2022 from

  • MLA

    Mandal, Ananya. "Vaccine Production". News-Medical. 07 August 2022. <>.

  • Chicago

    Mandal, Ananya. "Vaccine Production". News-Medical. (accessed August 07, 2022).

  • Harvard

    Mandal, Ananya. 2019. Vaccine Production. News-Medical, viewed 07 August 2022,


The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
You might also like...
Was there a benefit of vaccinating health care workers with a fourth dose of BNT162b2 vaccine during the Omicron outbreak?